{"id":"W3107960404","doi":"10.1097/cmr.0000000000000708","title":"Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)","year":2020,"lang":"en","type":"article","venue":"Melanoma Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Ipilimumab; Nivolumab; Medicine; Discontinuation; Expanded access; Internal medicine; Melanoma; Adverse effect; Oncology; Gastroenterology; Immunotherapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007166435,0.0002610881,0.000797745,0.0004350246,0.0001225568,0.00008692347,0.0004483755,0.00008913304,0.0001088417],"category_scores_gemma":[0.0007618429,0.0002171255,0.00005537166,0.002220909,0.0006197297,0.0002318363,0.0004058552,0.0008733739,0.00001510654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003932603,"about_ca_system_score_gemma":0.0003885672,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002154249,"about_ca_topic_score_gemma":0.001053806,"domain_scores_codex":[0.9954294,0.0005216351,0.000667728,0.0008422241,0.001782739,0.0007562528],"domain_scores_gemma":[0.9973522,0.0006813895,0.0001955122,0.0006264006,0.0006999122,0.0004445432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.108465,0.001755895,0.5703589,0.0001661596,0.0001528083,0.00008791468,0.00222159,0.00001670464,0.001356651,0.00000847619,0.00006658461,0.3153433],"study_design_scores_gemma":[0.06072845,0.009849124,0.9241726,0.0001434905,0.00002113281,0.00000175587,0.0003227333,0.00178704,0.002112973,0.000007920376,0.0006508669,0.0002018648],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937678,0.00009674187,0.00000997157,0.001088461,0.0000222519,0.003597852,0.0001349953,0.00007723223,0.001204673],"genre_scores_gemma":[0.9981251,0.0001578362,0.0005765679,0.00003469892,0.00005633209,0.000136174,0.0006168729,0.00006398974,0.000232369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3538137,"threshold_uncertainty_score":0.885412,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04357598447339473,"score_gpt":0.357439831923591,"score_spread":0.3138638474501962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}